Results 1 - 25 from 172 for "iasi"
-
Dr. Max Group Leases almost 12,000 Sqms of Logistic Spaces and Offices in ELI Park Iasi
10.21.2024
Dr. Max, a major player on Romania’s pharma market, has signed a leasing contract for 11,800 square meters in ELI Park Iasi, a project part of the portfolio of ELI Parks, one of the most dynamic more
-
Antibiotice Iasi Aims to Invest RON850M by 2030
10.02.2024
Romanian drug manufacturer Antibiotice Iasi has a RON850 million investment plan until 2030, covered through a funding mix, made up of cohesion funds, state aid, PNRR funds and EIB loan, stated more
-
Startup Munch Expands To Iasi
09.17.2024
Hungary-based startup Munch, which provides an application designed to help curb food waste and entered the Romanian market this spring, is expanding operations in the country to Iasi, where it more
-
Chimcomplex Bids To Take Over Heating Concession In Iasi
08.26.2024
Chemical producer and supplier Chimcomp0lex Borzesti (CRC.RO), which owns two industrial sites in Onesti and Ramnicu Valcea and is one of the largest entrepreneurial businesses in Romania, has more
-
Investment Fund Oresa Industra Aims to Double Its Iasi Logistics Area
08.19.2024
Oresa Industra currently has a 77,000-sqm portfolio concentrated in two logistic projects, a 35,000-sqm project in Iasi, and a 42,000-sqm one in Arad. more
-
Antibiotice Iasi Reports RON74M Net Profit For H1/2024, Up 20% YoY
08.14.2024
Romanian-owned drug manufacturer Antibiotice Iasi (stock symbol: ATB) ended the first half of 2024 with net profit of RON74 million, up 20% on the year, while its revenue rose by 8% to RON380 million, more
-
University Of Medicine And Pharmacy Of Iasi Gets EUR35.4M Loan From EIB
06.25.2024
Romania’s Grigore T. Popa University of Medicine and Pharmacy of Iasi (UMF Iasi) is borrowing EUR35.4 milion from the European Investment Bank (EIB) to refurbish and upgrade campus buildings. more
-
Affidea Invests EUR15M In Radiotherapy Center In Iasi
05.21.2024
Affidea, the largest player in the medical imaging services market in Romania, has completed the acquisition of MedEuropa radiotherapy centers, a deal announced in March 2024. The first step for the more
-
Antibiotice Iasi Records 13% Revenue Growth in Q1/2024. Net Profit Climbs 68%
05.15.2024
Antibiotice Iasi, the largest Romanian-owned drug manufacturer, saw revenues reach an overall RON192.5 million level, 13% higher than in the year-earlier period. more
-
Antibiotice Iasi Eyes RON850M Investments by 2030
04.30.2024
Antibiotice Iasi, the largest Romanian-held drug maker, has a total RON850 million investment plan between 2023-2030 to reach RON1 billion turnover at the end of this period. more
-
STRABAG Completes Construction Of T4 Terminal At Iasi International Airport Within EUR65.6M Project
03.29.2024
STRABAG, the European technology group for construction services, has completed the T4 terminal of the Iasi International Airport. more
-
Antibiotice Iasi Commissions 2.5 MW Photovoltaic Plant
03.28.2024
Pharma manufacturer Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, with total investments in the project amounting to RON11.8 million, of which RON4.07 million were granted by the more
-
Mobexpert Leases 1,400 Sqms of Warehousing Spaces in Oresa Industra Park of Iasi
03.26.2024
Furniture retailer Mobexpert is expanding its logistics and warehousing operations by leasing 1,400 square meters in logistic park Oresa Industra Park of Iasi owned by Oresa Industra, the real estate more
-
Antibiotice Iasi Wants to Cross RON100M Profit Threshold in 2024
03.25.2024
Antibiotice Iasi, the biggest Romanian-held drug manufacturer, wants to reach RON104 million net profit in 2024, up 28% from 2023, in line with its income and expenses budget. more
-
Antibiotice Iasi Seeks To Pay Dividends Of RON31M From 2023 Profit
03.14.2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) is summoning its shareholders to approve, among others, the distribution of RON31 million from the company's 2023 profit under the form of more
-
Antibiotice Iasi's Net Profit More Than Doubles YoY To RON80.7M In 2023
02.28.2024
Pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) ended 2023 with net profit of RON80.7 million, up 109.5% from 2022, and a turnover of RON600.8 million, up 7.2% on the year, in line with more
-
Iasi City Hall Buys 18 Trams from Turkey’s Bozankaya in RON141M Contract
02.20.2024
Bozankaya, a Turkish-held public transport vehicle producer, has gained a project within a tender organized by Iasi City Hall via which it will deliver the municipality 18 trams with a length of more
-
Antibiotice Iasi Launches New Vet Product Range
02.09.2024
Antibiotice Iasi, the largest Romanian-held pharma producer, is launching eight veterinary products in the range of nutritional supplements, complementing the company’s veterinary prescription more
-
Antibiotice Iasi Calls Shareholders To Approve Contracting RON35M Credit Facility From Banca Transilvania
01.25.2024
The Board of Directors of pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) announced in a stock market report on Thursday (Jan. 25, 2024) that it has called shareholders for a meeting on February more
-
Perfumery Brand Obsentum Opens First Store In NE Romania, In Iasi
12.19.2023
Perfumery brand Obsentum has opened its first store in northeastern Romania in Iasi, in the Palas shopping center, and has reached a network of nine niche perfumeries in the country. more
-
Kiddo Group Opens Hype Energize Centre in Palas Iasi
12.11.2023
Kiddo group, specializing in the development of play centers for kids and young people owned by Vlad Alexandru and Cristina Sucu, has opened a Hype Energize-branded center in Palas Iasi, with this more
-
ELI Parks Set to Launch New Development Project in Iasi
12.06.2023
ELI Parks, one of the most dynamic developers on Romania’s logistic and industrial market, wants to start a new development project, ELI Park Iasi, a logistic and industrial park with a total more
-
Romania Property Club: City Of Iasi To Attract Private Real Estate Investments Of EUR500M In Coming Years
11.27.2023
Romania's eastern city of Iasi will be attracting private real estate investments of EUR500 million in the coming years, which will add to public infrastructure projects worth EUR1.2 billion announced more
-
Antibiotice Iasi Shares To Be Included In MSCI Indices Starting With 1st Trading Day Of Dec 2023
11.16.2023
The Bucharest Stock Exchange has announced Wednesday evening that the shares of Antibiotice (ATB.RO), the Romanian manufacturer of generic drugs, listed on the local capital market for 26 years, will more
-
Antibiotice Iasi Ends 9M 2023 with RON463.4M Turnover, Up 28%, RON76M Net Profit, More than Double the 9M 2022 Level
11.15.2023
Romanian state-owned pharma producer Antibiotice Iasi for the first nine months of 2023 reported RON463.4 million turnover, up 28%, and RON76 million net profit, more than doubled the RON30 million more